Post Profile

Pfizer breast cancer drug superior to chemotherapy in late stage study

(Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.
read more


Related Posts

Pfizer, Lilly Drugs slow advanced breast cancer in studies

Health : The Checkup

Experimental breast cancer drugs from Pfizer and Eli Lilly slowed or halted the growth of advanced tumors in studies, potentially adding a new treatment option for patients and top-selling therapies for the companies. Read full arti...

AstraZeneca's Lynparza slows advanced breast cancer progression: study

Health : Reuters: Health

(Reuters) - Women with advanced breast cancer who carry specific genetic mutations experienced double the response rate and delayed disease progression when treated with AstraZeneca Plc's Lynparza compared with standard chemotherapy...

Experimental Pfizer Drug Slows Down Late Stage Breast Cancer

Health : Medical News Today

An experimental new drug by Pfizer has been proven to eliminate progression of an incurable form of breast cancer for over two years, according to new research presented at the San Antonio Breast Cancer Symposium. Patients were give...

Inherited BRCA1 Gene Mutation Associated With Better Response To Neoadjuvant Chemotherapy In Breast Cancer Patients

Health : Medical News Today

Nearly half of breast cancer patients carrying the BRCA1 gene mutation experience a complete pathological response (pCR) - the disappearance of all evidence of disease from the breast tissue and lymph nodes - regardless of disease s...

Roche lymphoma drug drives high remission rate, longer survival: study

Health : Reuters: Health

(Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment ...


Copyright © 2016 Regator, LLC